At a glance
- Originator Nonindustrial source
- Class Alkaloids; Antineoplastics
- Mechanism of Action Nucleoside transport protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 06 Jun 1997 Preclinical development for Cancer in South Korea (Unknown route)
- 06 Jun 1997 Preclinical development for Cancer in Taiwan (Intraperitoneal)
- 06 Jun 1997 Preclinical development for Cancer in Taiwan (PO)